TAIJI GROUP(SH:600129) Sou Hu Cai Jing·2025-06-29 19:11Core Viewpoint - The company, Taiji Group, is facing significant challenges, including a substantial decline in stock price and concerns regarding management's effectiveness in addressing competition and improving performance [2][3]. Group 1: Stock Performance - As of June 27, 2025, Taiji Group's stock closed at 21.22 yuan, down 0.52%, with a turnover rate of 1.49% and a trading volume of 83,100 shares, amounting to a transaction value of 177 million yuan [1]. - Over the past year and a half, the stock price has decreased by more than 70% [3]. Group 2: Management and Strategy - The management team is focusing on a strategy of "two focuses, two innovations" aimed at strengthening and optimizing major traditional Chinese medicine products, emphasizing technological and marketing innovations to drive performance recovery [2]. - The actual controller of the company has committed to resolving competition issues through various means, including asset swaps and management changes, while ensuring no new competition arises [3]. Group 3: Investor Communication - The company adheres to information confidentiality and fairness principles, stating that shareholder numbers and major shareholders will only be disclosed in regular reports [2]. - The company has received inquiries from investors regarding the management's actions and the commitment to resolving competition issues, indicating a need for clearer communication and transparency [3]. Group 4: Trading Information - On June 27, the net outflow of main funds was 18.81 million yuan, accounting for 10.64% of the total transaction value [4]. - Retail investors showed a net inflow of 3.59 million yuan, representing 2.03% of the total transaction value [5].